Published

Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Drug Science Policy and Law
Date: 2020-01-01
Source: OpenAlex
DOI: 10.1177/2050324520942345
PubMed: Unavailable

Authors

JEC Anthony Adam Winstock JA Ferris DJ Nutt

Watch author

Derived topics and classifications

psilocybin Receptor Pharmacology Observational Study Observational Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 20172020-01-01

Related papers

The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic ReviewJournal of Sociology Psychology & Religious Studies · 2023-11-06 Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?Journal of Humanistic Psychology · 2022-08-18 Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and PsilocybinThe Journal of Psychology · 1960-01-01 Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-19 A-118 Psychedelic Interventions for Neuropsychological ConditionsArchives of Clinical Neuropsychology · 2022-08-16 Psychedelic Psychotherapy: Insights From 25 Years of ResearchJournal of Humanistic Psychology · 2016-09-29 B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-12 Psychedelic Drug Therapy for Mental Disorders?Open Journal of Medical Psychology · 2023-01-01